AbbVie (ABBV) Other Accumulated Expenses (2012 - 2015)

AbbVie (ABBV) has reported Other Accumulated Expenses for 4 consecutive years, with $2.5 billion the latest figure, recorded in Q4 2015.

• On a quarterly basis, Other Accumulated Expenses rose 31.54% year-over-year to $2.5 billion in Q4 2015; TTM through Dec 2015 was $2.5 billion, a 31.54% increase from a year earlier, with the FY2015 full-year figure at $2.5 billion, up 31.54% from the prior year.
• Other Accumulated Expenses was $2.5 billion for Q4 2015 at AbbVie, up from $1.9 billion in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $2.5 billion in Q4 2015 and troughed at $1.5 billion in Q4 2013.
• A 4-year average of $1.9 billion and a median of $1.8 billion in 2012 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses decreased 10.88% in 2013 and soared 31.54% in 2015, its largest moves.
• Over 4 years, Other Accumulated Expenses stood at $1.7 billion in 2012, then dropped by 10.88% to $1.5 billion in 2013, then advanced by 26.32% to $1.9 billion in 2014, then soared by 31.54% to $2.5 billion in 2015.
• The last three Other Accumulated Expenses figures came in at $2.5 billion (Q4 2015), $1.9 billion (Q4 2014), and $1.5 billion (Q4 2013), per Business Quant data.